Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

0.89
EUR
0.00
(0.00%)
-2.43EPS
15.29MMarket Cap
Nov 12Next Earn

Latest Stock Split

Apr 17, 2025

1:3

For every 3 shares held, investors received 1.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Apr 17, 2025
    Before—
    Split ratio1:3
    After—
    Reverse
  2. Dec 31, 2024
    Before$0.35
    Split ratio1:12
    After$4.16
    Reverse

About Tvardi Therapeutics, Inc. stock splits

Tvardi Therapeutics, Inc. (GETTEX:69C) operates in the Biotechnology industry.

Tvardi Therapeutics, Inc. company overview

When did Tvardi Therapeutics, Inc. stock split?

Tvardi Therapeutics, Inc.'s most recent stock split was on April 17, 2025. It was a 1-for-3 reverse split, so shareholders received 1 share for every 3 they held.

What is Tvardi Therapeutics, Inc.'s stock split history?

Tvardi Therapeutics, Inc. (GETTEX:69C) has split its stock 2 times: a 1-for-12 reverse split on December 31, 2024 and a 1-for-3 reverse split on April 17, 2025.

How many times has Tvardi Therapeutics, Inc. stock split?

Tvardi Therapeutics, Inc. has split its stock 2 times. This history records 2 reverse splits between December 31, 2024 and April 17, 2025.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Tvardi Therapeutics, Inc.'s 1-for-3 reverse split on April 17, 2025, every 3 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Tvardi Therapeutics, Inc. split its stock again?

Tvardi Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on April 17, 2025, 1 year ago. Companies announce splits in advance, and any new GETTEX:69C split will appear on this page.